Technology

uBriGene's educational webinar series on ATMPs development and manufacturing

Embark on a journey from ATMPs concept to commercialization with uBriGene's groundbreaking webinar series. As leaders in the development...

New service launch - Cell therapy potency analytical development and GMP testing

We at uBriGene Biosciences are excited to launch the new Cell Therapy Potency Analytical Development and GMP Testing service at the...

Top 3 success factors for cell therapy potency assays

Do you know what FDA is looking for in the cell therapy potency assays? FDA published a guideline in Dec 2023 on CGT potency assay....

Correcting visual impairment: VGR-R01 project IND application accepted by Center for Drug Evaluation

A VGR-R01 project IND application from uBriGene partner Vitalgen has been accepted by the CDE, aiming to correct visual impairment On...

Assisted clinical application of gene therapy for Hemophilia B of Vitalgen accepted by NMPA

On April 21, 2022, according to the Chinese CDE (Center for Drug Evaluation) official website, the clinical trial application of VGB-R04...

Assisted clinical application of gene therapy in Ophthalmology of Innostellar accepted by NMPA

On January 26, 2022, pertaining to the announcement of Chinese CDE (Center for Drug Evaluation) official website, the clinical trial...

Canada